Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Investigative Radiology Année : 2014

Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study.

Résumé

Nephrogenic systemic fibrosis (NSF) has been related to the use of gadolinium-based contrast agents (GBCAs) in patients undergoing dialysis. The Prospective Fibrose Nephrogénique Systémique study, a French prospective study supported by the French drug regulatory agency (Agence Nationale de Sécurité du Médicament) and the French Societies of Nephrology, Dermatology, and Radiology, aimed at determining the incidence of NSF in patients undergoing long-term dialysis.
Fichier non déposé

Dates et versions

inserm-01102645 , version 1 (13-01-2015)

Identifiants

Citer

Sabine Amet, Vincent Launay-Vacher, Olivier Clément, Camille Frances, Aurore Tricotel, et al.. Incidence of nephrogenic systemic fibrosis in patients undergoing dialysis after contrast-enhanced magnetic resonance imaging with gadolinium-based contrast agents: the Prospective Fibrose Nephrogénique Systémique study.. Investigative Radiology, 2014, 49 (2), pp.109-15. ⟨10.1097/RLI.0000000000000000⟩. ⟨inserm-01102645⟩
309 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More